Scan to Download
Source: Bloomberg
Sasken Tech: The Bangalore-based software developer rose as much as 20 percent to record high of Rs 904 after it reported strong March quarter earnings.
Indian Hume Pipe: The Mumbai-based pipe maker rose as much as 9.55 percent, the most in nearly a month, to Rs 375 after it bagged Rs 578.50 crore order from Madhya Pradesh Jal Nigam Maryadit.
Unichem Labs: The Mumbai-based drug maker rose as much as 8.7 percent, the most in over three months, to Rs 283.10 after the U.S. FDA completed inspection of its Ghaziabad unit without any observations.
Minda Corp: The Noida-based electrical equipment maker rose as much as 18 percent to Rs 207.60. As many as 23.6 lakh shares or 1.1 percent equity changed hands in a block, Bloomberg data showed.
Buyers and sellers were not known immediately.
Source: Bloomberg
Shares of the pharmaceutical company rose as much as 8.2 percent, the most in over two months, to Rs 827.30.
Well-known investor Rakesh JhunJhunwala owned about 1.26 percent stake in the company, according to its stock exchange notification.
Jubilant Life Sciences trades at 21.7 times trailing 12-month earnings per share and 18 times its estimates for the coming year, Bloomberg data showed.
Has an invisible hand stepped in to support the Indian sovereign bond market? Traders are abuzz with speculation over the identity of the buyer or buyers behind the $862 million of purchases Friday. (Click here to read more.)
Shares of electrical equipment maker rose as much as 18.1 percent, the most in over seven months to Rs 207.60 after about 23.6 lakh shares or 1.1 percent equity changed hands in a block, Bloomberg data showed.
Buyers and sellers were not known immediately. Trading volume was 77.9 times its 20-day average. The stock rose 16 percent in the past month, compared to 1.8 percent gain in Sensex.
Buyers and sellers were not known immediately
Source: Bloomberg
Click here for more stock market data
Shares of the Ahmedabad-based agricultural processed products maker rose as much as 3.87 percent to record high of Rs 286.95.
The company informed exchanges that it has started commercial production at its 1,000 million tonnes per day green field maize processing plant at Chalisgaon in Maharashtra.
Shares of the Mumbai-based drug maker rose as much as 1.6 percent to Rs 812.85 after it received U.S. drug regulator's approval for generic Xenazine 12.5 mg and 25 mg tablets, Lupin said in an exchange filing.
The drug is used in treatment of Huntington's Disease.
Shares of the Mumbai-based drug maker rose as much as 14.67 percent to record high of Rs 2,020 after it informed exchanges that Procter & Gamble has proposed to buy 8.5 million shares of the company or 51.8 percent equity in the company, Merck said in an exchange filing on Thursday.
Source: Bloomberg
Shares of Bhushan Steel fell as much as 7.9 percent to Rs 33.20 after NCLT allowed Liberty House to bid for Bhushan Power.
Source: Bloomberg
Shares of the pipe manufacturer rose as much as 9.6 percent to Rs 375.
The company bagged Rs 578.50 crore order from Madhya Pradesh Jal Nigam Maryadit, according to its stock exchange notification.
Shares of the drug maker fell as much as 2.9 percent to Rs 572.15.
The pharmaceutical company received three observations from the U.S. drug regulator for its Pithampur unit, according to its exchange filing.
Cipla trades at 45.7 times trailing 12-month earnings per share and 28 times its estimates for the coming year. The stock has declined 6 percent so far this year.
TCS becomes the second company to enter $100 billion club; RIL's market cap had crossed $100 billion in 2007.https://t.co/4fMvvaetrX pic.twitter.com/a4DAqIpFHu
— BloombergQuint (@BloombergQuint) April 23, 2018
Walmart will take stake of 60-80 percent in India’s biggest e-commerce company with all existing investors backing the deal, people familiar with the matter said.
Source: Bloomberg
Buyers and sellers were not immediately known
Source: Bloomberg
Shares of the Bhopal-based road developer rose as much as 2.9 percent to Rs 1,162 after homegrown brokerage — Kotak Securities initiated coverage on the stock with a 'buy' for a target price of Rs 1,365 per share.
Kotak Securities on a note said:
Here’s how foreign and local funds played the market last Friday.https://t.co/HElpvECsyh pic.twitter.com/Pgl9j5OvfN
— BloombergQuint (@BloombergQuint) April 23, 2018
Kotak Securities on Dilip Buildcon
CLSA on Ashok Leyland
CLSA on HDFC Bank
MOSL on HDFC Bank
CLSA on Indiabulls Housing
Macquarie on Indiabulls Housing Finance
CLSA on India Strategy
Indiabulls Housing Finance Q4 Profit Jumps 22.5%
L&T Infotech
Ajmera Realty
Moldtek Technologies
Scandals, Bad Debts at India Banks Threaten Economic Outlook
These are some important events coming up this week:
Commodities
Essential Business Intelligence, Continuous LIVE TV, Sharp Market Insights, Practical Personal Finance Advice and Latest Stories — On NDTV Profit.
